Human papillomavirus DNA in cervical lesions from Morocco and its implications for cancer control

Clinical Microbiology and Infection

Volumn 9, Issue 2, 2003, Pages 144-148

  Lalaoui, K ^a   El Mzibri, M ^a   Amrani, M ^b   Belabbas, M A ^b   Lazo, P A ^c  

^a CENTRE NATIONAL DE L ENERGIE DES SCIENCES TECHNIQUES NUCLEAIRES   (Morocco)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Morocco)

^c Centro de Investigacion del Cancer   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS VACCINE;

ARTICLE; CANCER CONTROL; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HUMAN; HUMAN TISSUE; MOROCCO; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; VACCINATION; VIRUS IDENTIFICATION; VIRUS TYPING; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0038752831     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00494.x     Document Type: Article

References (23)

1. Bosch FX, Manos MM, Muñoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
2. McGlennen RC. Human papillomavirus oncogenesis. Clin Lab Med 2000; 20: 383-406.
3. Bergeron C, Barrasso R, Beaudenon S, Flamant P, Croissant O, Orth G. Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions. Am J Surg Pathol 1992; 16: 641-9.
4. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92: 690-8.
5. Vernon SD, Unger ER, Miller DL, Lee DR, Reeves WC. Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int J Cancer 1997; 74: 50-6.
6. Lazo PA. Papillomavirus integration: prognostic marker in cervical cancer? Am J Obstet Gynecol 1997; 176: 1121-2.
7. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
8. Jacobs MV, Snijders PJ, Voorhorst FJ et al. Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J Clin Pathol 1999; 52: 498-503.
9. Chaouki N, Bosch FX, Muñoz N et al. The viral origin of cervical cancer in Rabat, Marocco. Int J Cancer 1998; 75: 546-54.
10. International Federation of Gynecology and Obstetrics. Staging announcement: FIGO staging of gynecologic cancers: cervical and vulva. Int J Gynecol Cancer 1995; 5: 319-21.
11. Greer CE, Wheeler CM, Manos MM. PCR amplification from paraffin-embedded tissues: sample preparation and the effects of fixation. In: Dieffenbach CW, Dveksler GS, eds. PCR Primer: a Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1995: 99-112.
12. Fernandez-Contreras ME, Sarria C, Nieto S, Lazo PA. Amplification of human genomic sequences by human papillomaviruses universal consensus primers. J Virol Methods 2000; 87: 171-5.
13. Bauer HM, Greer CE, Manos MM. Determination of genital human papillomavirus infection by consensus PCR amplification. In: McGee JO, ed. Diagnostic Molecular Pathology. Oxford: Oxford University Press, 1992: 131-52.
14. Wallin K, Wiklund F, Angstrom T et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical carcinoma. N Engl J Med 1999; 341: 1633-8.
15. Josefsson AM, Magnusson PK, Ylitalo N et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000; 355: 2189-93.
16. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
17. Lazo PA. The molecular genetics of cervical carcinoma. Br J Cancer 1999; 80: 2008-18.
18. Ylitalo N, Sorensen P, Josefsson AM et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000; 355: 2194-8.
19. Breitburd F, Coursaget P. Human papillomavirus vaccines. Semin Cancer Biol 1999; 9: 431-44.
20. Harro CD, Pang YY, Roden RB et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16, L1 virus-like particle vaccine. J Natl Cancer Inst 2001; 93: 284-92.
21. HPV vaccines: Promise and challenges on World Wide Web URL. http://www.path.org//files/isrp1370.pdf.
22. Thomas KK, Hughes JP, Kuypers JM et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000; 182: 1097-102.
23. Liaw KL, Hildesheim A, Burk RD et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001; 183: 8-15.